Medical Research
Treatments For Epilepsy And Symptoms Of Slc13A5 Foundation
MENLO PARK, CA
Total revenue
$542K
Total expenses
$584K
Net assets
$406K
Grants received
$1.2M
26 grants
EIN
473108868
Tax year
2024
Mission
Tess Research Foundations goal is to find better treatment options for SLC13A5 deficiency, (Continued on Sch O)
Programs
2 programs
Education, Family Support and Awareness - We are the only organization dedicated to supporting families with SLC13A5 Epilepsy and raising awareness about the disease. Our ongoing program includes sharing updates about the latest research findings and connecting and empowering families so they can share their experiences and support one another. We have an annual awareness day (May 13), host monthly virtual support calls, maintain a website, and send a monthly electronic newsletter.
Conference - We continue to create a patient-centered network of doctors, researchers, clinicians, and families. TESS hosted the largest-ever SLC13A5 family and professional conference in Providence, Rhode Island. We attend neurology, epilepsy, and drug development conferences.
Financials
FY 2024
Revenue
Expenses
People
13 listed
Amber Black
Secretary
$68K
40 hrs/wk
Paula Gani
Director
—
3 hrs/wk
Courtney Alberti
Director
—
2 hrs/wk
Adam Alberti
Director
—
2 hrs/wk
Lee Scheuer
Director
—
3 hrs/wk
Robert Wassman
Director
—
3 hrs/wk
Don Neault
Director
—
3 hrs/wk
Janet Wojcicki
Director
—
3 hrs/wk
Megan Gilbert
Director
—
3 hrs/wk
Rich Windisch
Director
—
3 hrs/wk
Kimberly Nye
Chair & Executive Director
—
40 hrs/wk
Kevin McDonnell
Treasurer
—
3 hrs/wk
Michael Black
Vice Chair
—
5 hrs/wk
Grants received
Showing 26 of 26
Funded by
$1.2M from 10 funders · 26 grants · 2017–2024
$708K · 4 grants · 2020–2024
$204K · 6 grants · 2019–2023
$172K · 7 grants · 2017–2023
$19K · 2 grants · 2023–2024
$14K · 2 grants · 2023–2024
$10K · 1 grant · 2023
$9K · 1 grant · 2023
$8K · 1 grant · 2017